ALNYLAM PHARMACEUTICALS, INC. 8-K

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

May 2, 2016

Period of Report

April 29, 2016

Accession Number

0001157523-16-005377

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →